Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome

Neurology India

Volumn 59, Issue 5, 2011, Pages 727-732

  Kannan, Meena A ^a   Ch, Rathna Kishore ^a   Jabeen, S A ^a   Rukmini Mridula, K ^a   Rao, Pragnya ^b   Borgohain, R ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

^b KAMINENI HOSPITALS   (India)

Author keywords

Acute axonal motor neuropathy; acute inflammatory demyelinating polyradiculoneuropathy; antiganglioside antibodies; Guillain Barr syndrome

Indexed keywords

GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM2; GANGLIOSIDE GM3; GANGLIOSIDE GQ 1B; GANGLIOSIDE GT 1B; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACUTE DISEASE; ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; ACUTE MOTOR AXONAL NEUROPATHY; ADOLESCENT; ADULT; ARTICLE; AUTONOMIC DYSFUNCTION; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONVALESCENCE; CRANIAL NERVE PARALYSIS; DIARRHEA; DISEASE CLASSIFICATION; DISEASE SEVERITY; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; GASTROENTERITIS; GM1 GANGLIOSIDOSIS; GUILLAIN BARRE SYNDROME; HUMAN; INFANT; MALE; NERVE CONDUCTION; NEUROPATHY; POLYRADICULONEUROPATHY; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SENSORY DYSFUNCTION; WEAKNESS;

ADOLESCENT; AUTOANTIBODIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; ELECTROCARDIOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GANGLIOSIDES; GUILLAIN-BARRE SYNDROME; HUMANS; INFANT; MALE; NEURAL CONDUCTION; RETROSPECTIVE STUDIES; SEASONS; SEX FACTORS;

EID: 81155139028     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.86549     Document Type: Article

References (31)

1. Asbury AK, Arnason BG, Adams RD. The inflammatory lesion in idiopathic polyneuritis: Its role in pathogenesis. Medicine (Baltimore) 1969;48:173-215.
2. Olive JM, Castillo C, Castro RG, de Quadros CA. Epidemiological study of Guillain-Barre syndrome in children <15 years of age in Latin America. J Infect Disease 1997;175:S160-4
3. Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet 2005;366:1653-66.
4. Winer JB, Hughes RA, Anderson MJ, Jones DM, Kangro H, Watkins R P. A prospective study of acute idiopathic neuropathy; II. Antecedent events. J Neurol Neurosurg Psychiatry 1988;51:613-8.
5. Bradshaw DJ, Jones HR Jr. Guillain-Barre syndrome in children: Clinical course, electrodiagnosis, and prognosis. Muscle Nerve 1992;15:500-6.
6. Hartung HP, Kieseier BC, Kiefer R. Progress in Guillain-Barre syndrome. Curr Opin Neurol 2001;14:597-604.
7. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for GB syndrome. Ann Neurol 1990;27 (suppl):521-4.
8. McKhann GM, Cornbloth DR, Griffin JW, Ho TW, Li CY, Jiang Z, et al. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in china. Annl Neurol 1993;33:333-42.
9. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, et al. An acute axonal form of Guillain-Barre syndrome polyneuropathy. Brain 1986;109:1115-26.
10. Griffin JW, Licy, Ho TW, Tian M, Gao CY, Xue P, et al. Pathology of the motor-sensory axonal GB syndrome. Ann Neurol 1996;39:17-28.
11. Hartung HP, Pollard JD, Harvey GK, Toyka K V. Immunopathogenesis and treatment of the Guillain-Barre syndrome-Part I. Muscle Nerve 1995;18:137-53.
12. Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQlb IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barre syndrome. Brain Res 1997;745:32-6.
13. Higara A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, et al. Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome. Neurology 2005;64:856-60.
14. 1, GDlb, peripheral nerve myelin and campylobacter jejuni in patients with GB syndrome and controls: Correlation and prognosis. Ann Neurol 1993;34:130-5.
15. Briscoe DM, McMenamin JB, Donohoe N V. Prognosis in Guillain-Barre syndrome. Arch Dis Child 1987;62:733-5.
16. Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of Prednisolone in acute polyneuropathy. Lancet 1978;2:750-3.
17. Martinez AC, Ferrer MT, Conde MC, Bernacer M. Motor conduction velocity and H reflexes in infancy and childhood: II Intr and extrauterine maturation of the nerve fibres; development of the peripheral nerves from one month to 11 years of age. Electromyogr Clin Neurophysiol 1978;8:11-27.
18. Dunn HG, Buchler J, Morrison SC, Emery AW. Conduction velocity of motor nerves in infants and children. Pediatrics 1964;34:708-27.
19. Swoboda KJ. An approach to pediatric electromyography. In: Jones HR Jr, De Vivo DC, Darras BT, editors. Neuromuscular disorders of infancy, childhood, and adolescence. Philadelphia: Butterworth-Heineman, Elsevier 2003. p. 35-74.
20. Ho TW, Li CY, Ho TW, Xue P, Macko C, Gao CY, et al. GB syndrome in northern China: The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-95.
21. Paradiso G, Tripoli J, Galicchio S, Fejerman N. Epidemiological, clinical and electrodiagnostic findings in childhood Guillain-Barre Syndrome: A reappraisal. Ann Neurol 1999;46:701-7.
22. Nachamkin I, Arzarte Barbosa P, Ung H, Lobato C, Gonzalez Rivera A, Rodriguez P, et al. Patterns of Guillain-Barre syndrome in children: Results from a Mexican population. Neurology 2007;69:1665-71.
23. Tekgul H, Serdaroglu G, Tutuncuoglu S. Outcome of axonal and demyelinating forms of Guillain-Barre syndrome in children. Pediatr Neurol 2003;28:295-9.
24. Winer JB, Hughes RA, Osmond C. A prospective study of acute idiopathic neuropathy; I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1998;51:605-12.
25. Hung PL, Chang WN, Huang LT, Huang SC, Chang YC, Chang CJ, et al. A clinical and electrophysiologic survey of childhood Guillain-Barré syndrome. Pediatr Neurol 2004;30:86-91.
26. Nagasawa K, Kuwabara S, Misawa S, Fujii K, Tanabe Y, Yuki N, et al. Electrophysiological subtypes and prognosis of childhood Guillain-Barre syndrome in Japan. Muscle Nerve 2006;33:766-70.
27. Hughes RA, Rees JH. Clinical and epidemiological features of GB syndrome. J Infect Dis 1997;176 (Suppl 2):S92-8.
28. Higara A, Mori M, Ogawara K, Kojima S, Kuwabara. Recovery patterns and long-term prognosis for axonal GB syndrome. JNNP 2005;76:719-22.
29. Ashok Kumar Reddy B, Meena AK. Clinical, electrophysiological patterns and outcome of Guillain-Barre syndrome in relation to antiganglioside antibodies. Dissertation: NIMS, 2007.
30. Reuben S, Mathai A, Sumi MG, Nair MD, Radhakrishnan V V. Significance of serum antibody to GD1b ganglioside in patients with Guillain-Barre syndrome. Indian J Med Res 2001;113:234-8.
31. Menon A, Patil SA, Taly AB, Vasanth A. Anti-ganglioside antibodies in GB syndrome: Do they indicate prognosis. Ann IAN 2003;6: 11-6.